July 9, 2019
BioMarin to Submit Hemophilia A Gene Therapy to U.S. and European Regulators in Q4
Read More
June 4, 2019
EU Grants Conditional Approval for Bluebird Bio’s Beta-Thalassemia Gene Therapy
Read More
May 29, 2019
GenSight Will Seek Approval for Gene Therapy for Rare Eye Disease Strength of Sham Treatment
Read More
May 24, 2019
FDA Approves Gene Therapy Zolgensma for SMA; Novartis Sets Price at $2.1 Million
Read More
May 6, 2019
AveXis’ Gene Therapy Shows Promise Across Spectrum of SMA Patients
Read More
April 30, 2019
Abeona Reports Preclinical Data of Experimental CF Gene Therapy
Read More
April 22, 2019
Novartis Investigating Patient Death in SMA Gene Therapy Trial
Read More
April 18, 2019
St. Jude Gene Therapy “Cures” Babies with “Bubble Boy” Disease
Read More
April 4, 2019
FDA Grants Abeona Fast Track Designation for Sanfilippo Type B Gene Therapy
Read More
April 2, 2019
Sangamo Provides Positive Updates on Hemophilia A and Beta Thalassemia Gene Therapy Trials
Read More
April 2, 2019
AveXis Expands Gene Therapy Manufacturing Capacity with Acquisition
Read More
April 1, 2019
EMA Grants Krystal Biotech PRIME Designation for DEB Gene Therapy
Read More
Load More
X